FDA official clarifies cGMP expectations for investigational drugs
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesManufacturingPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesManufacturingPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)